An audit to assess the impact of new directives about the use of aprotinin on re-exploration rates and blood product usage after adult cardiac surgery.
暂无分享，去创建一个
[1] B. Spiess,et al. Case 1-2008. One institution's decreasing use of aprotinin during cardiac surgery in 2006. , 2008, Journal of cardiothoracic and vascular anesthesia.
[2] Jeremiah R. Brown,et al. Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery , 2007, Circulation.
[3] T. Treasure,et al. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. , 2004, The Journal of thoracic and cardiovascular surgery.
[4] A. Laupacis,et al. Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery: Meta-Analyses Using Perioperative Blood Transfusion As the Outcome , 1997, Anesthesia and analgesia.